OverviewChartNewsTraderScreen

UBS Knock-Out AMGN/  DE000UL9EFZ9  /

UBS Investment Bank
10/11/2024  9:50:34 PM Chg.+0.070 Bid- Ask- Underlying Strike price Expiration date Option type
0.580EUR +13.73% -
Bid Size: -		 -
Ask Size: -		 Amgen Inc 267.4213 USD 12/31/2078 Call
TeleTrader 9/25 Dow falls 290 pts at close as S&P 500 slips from record highs
GlobeNewswire 8/29 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire 8/28 Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire 8/26 Molecular Partners Reports H1 2024 Corporate Highlights and Financials
GlobeNewswire 8/26 Eliem Therapeutics Announces Additions to its Leadership Team
GlobeNewswire 8/15 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire 8/12 TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 8/8 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/8 Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
TeleTrader 8/7 US closes lower with earnings in focus
TeleTrader 8/7 US turns red, Dow loses more than 200 pts
GlobeNewswire 8/7 89bio Appoints Francis Sarena as Chief Operating Officer
TeleTrader 8/6 Amgen books revenue of $8.4B in Q2, up 20%
TeleTrader 8/6 US extends premarket gains, Dow surges 250 pts
GlobeNewswire 8/5 Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
TeleTrader 8/1 Dow jumps 250 pts as Meta surges more than 10%
GlobeNewswire 8/1 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 7/22 Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 202...
GlobeNewswire 7/9 ImCheck Appoints Stephan Braun as Chief Medical Officer
GlobeNewswire 7/2 Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Bi...
GlobeNewswire 7/1 Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer
GlobeNewswire 6/27 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire 6/27 Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...
GlobeNewswire 6/26 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 6/26 Compass Pathways appoints Lori Englebert as Chief Commercial Officer